KRASG12C inhibitor combination therapy in metastatic non-small-cell lung cancer: choosing the right path

The Lancet Oncology 2026

View at publisher

Authors: Tämer El Saadany, Adrian Gerold Sacher

DOI: 10.1016/s1470-2045(26)00119-1

Cited by: 1

References: 9

Fields of Study & Subjects

Protein Kinase Regulation and GTPase Signaling HER2/EGFR in Cancer Research Protein Tyrosine Phosphatases

References 9